TMO Thermo Fisher Scientific Inc Common Stock
Acerca de Thermo Fisher Scientific Inc Common Stock Descripción general de la empresa de Wikipedia
Thermo Fisher Scientific es una multinacional estadounidense dedicada al desarrollo de productos de biotecnología. Fue creada en 2006 por la fusión de Thermo Electron y Fisher Scientific. En abril de 2013, tras una licitación pública con Hoffmann-La Roche, Thermo Fisher adquirió Life Technologies Corp por $ 13.6 mil millones en un acuerdo que ubicaría a la empresa como una de las empresas líderes en los mercados de equipos de pruebas genéticas y de laboratorio de precisión.
Leer más
Thermo Fisher Scientific es una multinacional estadounidense dedicada al desarrollo de productos de biotecnología. Fue creada en 2006 por la fusión de Thermo Electron y Fisher Scientific. En abril de 2013, tras una licitación pública con Hoffmann-La Roche, Thermo Fisher adquirió Life Technologies Corp por $ 13.6 mil millones en un acuerdo que ubicaría a la empresa como una de las empresas líderes en los mercados de equipos de pruebas genéticas y de laboratorio de precisión.
## Predecesores y fusión
Thermo Electron fue cofundada en 1956 por George N. Hatsopoulos y Peter M Nomikos. Hatsopoulos es un doctorado del MIT en ingeniería mecánica y Nomikos un graduado de la Escuela de Negocios de Harvard. Se centró en el suministro de productos y servicios analíticos y de laboratorio, y tuvo unos ingresos de más de $ 2 mil millones en 2004
Fisher Scientific fue fundada en 1902 por Chester G. Fisher originario de Pittsburgh. Se centró en el suministro de equipos de laboratorio, productos químicos, suministros y servicios utilizados en la asistencia sanitaria, la investigación científica, seguridad y educación.
El 14 de mayo de 2006 Thermo Electron y Fisher Scientific anunciaron que se iban a fusionar en un intercambio libre de impuestos; y la compañía pasó a llamarse Thermo Fisher Scientific. El 9 de noviembre de 2006 las compañías anunciaron que la fusión había sido completada. Sin embargo, la Comisión Federal de Comercio dictaminó que esta adquisición era contraria a la competencia con respecto a los evaporadores centrífugos, requiriendo a Fisher desinvertir en Genevac. En abril de 2007, Genevac fue vendida a Riverlake Partners LLC y la adquisición cerro con la aprobación de la Comisión Federal de Comercio.
Actualmente los productos de la compañía son vendidos bajo los nombres de Thermo Scientific, Fisher Scientific, y muchas otras marcas reconocidas (ej. Chromacol, Nalgene, Cellomics, Cole-Parmer, Pierce Protein Research y Fermentas). Según cifras de la compañía, el 46% de sus ventas es en el campo de ciencias de la vida, el 20% en tecnologías sanitarias, y el 34% en el campo de la industria ambiental y la seguridad.
Thermo Fisher tiene oficinas y centros operacionales en muchos países, mayormente en Estados Unidos y en Europa.
En mayo de 2011, Thermo Fisher Scientific Inc. adquirió Phadia para expandirse en el sector de pruebas contra alergias y enfermedades autoinmunes por 2.47 mil millones de euros (3.5 mil millones de dólares).
En abril de 2021, Thermo Fisher anunció la adquisición de PPD, Inc., una organización de investigación por contrato, por un precio total de compra en efectivo de $17,400 millones, más la asunción de aproximadamente $3,500 millones de deuda neta. PPD generó $4700 millones en ingresos durante el año fiscal 2020 y esta transacción, que valora su empresa en aproximadamente $20 900 millones. En noviembre, la empresa anunció que adquiriría PharmaFluidics y su gama μPAC de productos de cromatografía basados en microchips.
== Referencias ==
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
TMO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
TMO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto |
|---|---|
| 15 de junio de 2026 | $0,4700 |
| 13 de marzo de 2026 | $0,4700 |
| 15 de diciembre de 2025 | $0,4300 |
| 15 de septiembre de 2025 | $0,4300 |
| 13 de junio de 2025 | $0,4300 |
| 14 de marzo de 2025 | $0,4300 |
| 13 de diciembre de 2024 | $0,3900 |
| 13 de septiembre de 2024 | $0,3900 |
| 14 de junio de 2024 | $0,3900 |
| 14 de marzo de 2024 | $0,3900 |
| 14 de diciembre de 2023 | $0,3500 |
| 14 de septiembre de 2023 | $0,3500 |
| 14 de junio de 2023 | $0,3500 |
| 14 de marzo de 2023 | $0,3500 |
| 14 de diciembre de 2022 | $0,3000 |
| 14 de septiembre de 2022 | $0,3000 |
| 14 de junio de 2022 | $0,3000 |
| 15 de marzo de 2022 | $0,3000 |
| 14 de diciembre de 2021 | $0,2600 |
| 14 de septiembre de 2021 | $0,2600 |
TMO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 11 30,6%
- Compra 18 50,0%
- Mantener 7 19,4%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
26 analistas · 2026-08-14Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $6.03 | $5.77 | 0.26% |
| 31 de marzo de 2026 | $5.44 | $5.29 | 0.15% |
| 31 de diciembre de 2025 | $6.57 | $6.51 | 0.06% |
| 30 de septiembre de 2025 | $5.79 | $5.55 | 0.24% |
| 30 de junio de 2025 | $5.36 | $5.28 | 0.08% |
| 31 de marzo de 2025 | $5.15 | $5.15 | -0.00% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $8.21B | $7.58B | |
| R&D Expense | $1.40B | $1.39B | $1.34B | $1.47B | $1.41B | $1.18B | $1.00B | $967M | · | $754M | $692M | |
| SG&A Expense | $8.73B | $8.60B | $8.45B | $8.99B | $8.01B | $6.93B | $6.14B | $6.06B | · | $4.97B | $4.61B | |
| Operating Expenses | $36.81B | $35.54B | $36.00B | $36.52B | $29.18B | $24.42B | $20.95B | $20.57B | · | $15.82B | $14.63B | |
| Operating Income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $3.78B | · | $2.46B | $2.34B | |
| Interest Expense | · | · | $1.38B | $726M | $536M | $553M | $676M | $667M | · | $469M | $415M | |
| Interest Income | $993M | $1.08B | $879M | $272M | $43M | $65M | $224M | $137M | · | $48M | $31M | |
| Other Non-op | $-12M | $12M | $-65M | $-104M | $-694M | $-76M | $-70M | $9M | · | $-13M | $-16M | |
| Pretax Income | $7.31B | $7.04B | $6.30B | $7.83B | $8.84B | $7.23B | $4.07B | $3.26B | · | $2.02B | $1.94B | |
| Income Tax | $547M | $657M | $284M | $703M | $1.11B | $850M | $374M | $324M | · | $-1M | $-44M | |
| Net Income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | · | · | · | · | |
| EPS (Basic) | $17.77 | $16.58 | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | · | $5.12 | $4.96 | |
| EPS (Diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | · | $5.09 | $4.92 | |
| Shares (Basic) | 377,000,000 | 382,000,000 | 386,000,000 | 392,000,000 | 394,000,000 | 396,000,000 | 400,000,000 | 402,000,000 | · | 395,000,000 | 399,000,000 | |
| Shares (Diluted) | 378,000,000 | 383,000,000 | 388,000,000 | 394,000,000 | 397,000,000 | 399,000,000 | 403,000,000 | 406,000,000 | · | 397,000,000 | 402,000,000 | |
| EBITDA | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $6.05B | · | $4.21B | $4.02B |
Balance general 28
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B | $10.32B | $2.40B | $2.10B | · | $786M | $452M | |
| Short-term Investments | $253M | $1.56B | $3M | · | · | · | · | · | · | · | · | |
| Receivables | $8.90B | $8.19B | $8.22B | $8.12B | $7.98B | $5.74B | $4.35B | $4.14B | $3.87B | $3.05B | $2.54B | |
| Inventory | $5.42B | $4.98B | $5.09B | $5.63B | $5.05B | $4.03B | $3.37B | $3.00B | $2.72B | $2.21B | $1.99B | |
| Other Current Assets | $2.61B | $1.96B | $1.76B | $1.64B | $1.64B | $1.13B | $1.17B | $922M | $1.47B | $595M | $534M | |
| Current Assets | $28.71B | $22.14B | $24.59B | $25.23B | $20.11B | $21.96B | $11.89B | $10.62B | · | $7.02B | $5.74B | |
| PP&E (Net) | $10.56B | $9.31B | $9.45B | $9.28B | $8.33B | $5.91B | $4.75B | $4.17B | · | $2.58B | $2.45B | |
| PP&E (Gross) | $18.38B | $16.06B | $15.52B | $14.27B | $12.59B | $9.58B | $7.76B | $6.82B | · | $4.42B | $4.11B | |
| Accum. Depreciation | $7.82B | $6.75B | $6.08B | $4.99B | $4.26B | $3.67B | $3.02B | $2.65B | · | $1.84B | $1.66B | |
| Goodwill | $49.36B | $45.85B | $44.02B | $41.20B | $41.92B | $26.04B | $25.71B | $25.35B | · | $21.33B | $18.83B | |
| Intangibles | $15.84B | $15.53B | $16.67B | $17.44B | $20.11B | $12.69B | $14.01B | $14.98B | · | $13.97B | $12.76B | |
| Other Non-current Assets | $5.87B | $4.49B | $4.00B | $4.01B | $4.64B | $2.46B | $2.01B | $1.12B | $1.17B | $1.01B | $1.06B | |
| Total Assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Accounts Payable | $3.62B | $3.08B | $2.87B | $3.38B | $2.87B | $2.17B | $1.92B | $1.61B | · | $926M | $822M | |
| Short-term Debt | · | · | · | · | · | · | · | $693M | · | $953M | $50M | |
| Current Liabilities | $15.19B | $13.33B | $14.01B | $17.01B | $13.44B | $10.30B | $6.20B | $6.15B | · | $4.87B | $4.15B | |
| Capital Leases | $1.20B | $1.24B | $1.24B | $1.31B | $1.20B | $626M | $571M | · | · | · | · | |
| Deferred Tax | $1.49B | $1.27B | $1.92B | $2.85B | $3.84B | $1.79B | $2.19B | $2.27B | $2.71B | $2.56B | $2.62B | |
| Other Non-current Liabilities | $4.27B | $3.99B | $4.64B | $4.24B | $4.54B | $3.33B | $3.24B | $2.52B | $2.64B | $1.57B | $1.29B | |
| Long-term Debt | $39.17B | $31.07B | $34.73B | $34.28B | $34.67B | $21.73B | $17.75B | $18.99B | · | · | · | |
| Total Debt | · | · | · | · | · | $19.11B | $17.08B | $693M | · | $953M | $50M | |
| Common Stock | $445M | $444M | $442M | $441M | $439M | $437M | $434M | $432M | · | $415M | $412M | |
| Retained Earnings | $59.16B | $53.10B | $47.36B | $41.91B | $35.43B | $28.12B | $22.09B | $18.70B | $16.03B | $13.93B | $12.14B | |
| Treasury Stock | $22.31B | $19.23B | $15.13B | $12.02B | $8.92B | $6.82B | $5.24B | $3.67B | · | $2.31B | $1.01B | |
| AOCI | $-2.45B | $-2.70B | $-3.22B | $-3.10B | $-2.33B | $-2.81B | $-2.68B | $-2.50B | $-2.09B | $-2.64B | $-2.00B | |
| Stockholders' Equity | $53.41B | $49.58B | $46.73B | $43.98B | $40.79B | $34.51B | $29.68B | $27.59B | · | $21.54B | $21.35B | |
| Liabilities + Equity | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Shares Outstanding | 445,000,000 | 444,000,000 | 442,000,000 | 441,000,000 | 439,000,000 | 437,000,000 | 434,000,000 | · | · | · | · |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2.27B | · | $1.76B | $1.69B | |
| Stock-based Comp | $310M | $301M | $278M | $307M | $230M | $196M | $181M | $181M | · | $133M | $125M | |
| Deferred Tax | $-639M | $-1.21B | $-1.30B | $-997M | $-645M | $-269M | $-499M | $-474M | · | $-639M | $-600M | |
| Amort. of Intangibles | $1.73B | $1.95B | $2.34B | $2.40B | $1.76B | $1.67B | $1.71B | $1.74B | · | $1.38B | $1.31B | |
| Restructuring | $197M | $97M | $194M | $68M | $37M | $51M | $52M | $88M | · | $167M | $90M | |
| Operating Cash Flow | $7.82B | $8.67B | $8.41B | $9.15B | $9.31B | $8.29B | $4.97B | $4.54B | · | $3.26B | $2.94B | |
| CapEx | $1.52B | $1.40B | $1.48B | $2.24B | $2.52B | $1.47B | $926M | $758M | · | $444M | $423M | |
| Investing Cash Flow | $-4.05B | $-5.84B | $-5.14B | $-2.16B | $-21.93B | $-1.51B | $-1.49B | $-1.25B | · | $-5.52B | $-1.09B | |
| Debt Issued | $7.76B | $1.20B | $5.94B | $3.19B | $18.14B | $3.46B | $5.64B | $690M | · | $7.60B | $1.80B | |
| Net Debt Issued | $5.35B | $-2.40B | $160M | $2.82B | $6.40B | $2.75B | $-722M | $-1.36B | · | $3.27B | $-1.98B | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | |
| Stock Repurchased | $3.00B | $4.00B | $3.00B | $3.00B | $2.00B | $1.50B | $1.50B | $500M | · | $1.25B | $500M | |
| Net Stock Activity | $-3.00B | $-4.00B | $-3.00B | $-3.00B | $-2.00B | $-1.50B | $-1.50B | $-500M | · | $-1.25B | $-500M | |
| Dividends Paid | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M | |
| Financing Cash Flow | $1.80B | $-6.79B | $-3.62B | $-2.81B | $6.58B | $959M | $-3.12B | $-2.24B | · | $2.76B | $-2.62B | |
| Net Change in Cash | $5.84B | $-4.06B | $-440M | $4.05B | $-5.84B | $7.91B | $305M | $756M | · | $345M | $-898M | |
| Taxes Paid | $1.78B | $1.83B | $1.48B | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $6.29B | $7.27B | $6.93B | $6.91B | $6.79B | $6.82B | $4.05B | $3.79B | · | $2.71B | $2.39B | |
| Levered FCF | · | · | $5.61B | $6.25B | $6.32B | $6.33B | $3.43B | $3.18B | · | $2.24B | $1.97B |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | · | 13.4% | 13.8% | |
| Net Margin | 15.0% | 14.8% | 13.9% | 15.5% | 19.7% | · | · | · | · | · | · | |
| Pretax Margin | 16.4% | 16.4% | 14.7% | 17.4% | 22.6% | 22.4% | 15.9% | 13.4% | · | 11.1% | 11.4% | |
| EBITDA Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 24.8% | · | 23.0% | 23.7% | |
| ROA | 6.5% | 6.4% | 6.1% | 7.2% | 9.4% | · | · | · | · | · | · | |
| ROE | 13.0% | 13.2% | 13.1% | 16.4% | 19.9% | · | · | · | · | · | · | |
| ROIC | 13.4% | 13.4% | 14.0% | 17.4% | 21.5% | 12.8% | 8.9% | 12.0% | · | 10.9% | 11.2% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.7 | 1.8 | 1.5 | 1.5 | 2.1 | 1.9 | 1.7 | · | 1.4 | 1.4 | |
| Quick Ratio | 1.3 | 1.0 | 1.2 | 1.0 | 0.9 | 1.6 | 1.1 | 1.0 | · | 0.8 | 0.7 | |
| Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | 0.0 | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | · | · | · | · | |
| Interest Coverage | · | · | 5.0 | 11.6 | 18.7 | 14.1 | 6.8 | 5.7 | · | 5.2 | 5.6 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 3.9 | 3.9 | |
| Receivables Turnover | 5.2 | 5.2 | 5.2 | 5.6 | 5.7 | 6.4 | 6.0 | 6.1 | · | 6.5 | 6.8 |
Tasas de Crecimiento 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | 0.05% | -4.6% | 14.5% | 21.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.27% | 3.0% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.3% | 7.0% | -12.4% | -9.4% | 21.9% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 0.21% | -5.3% | -1.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 5.8% | 5.7% | -13.9% | -9.9% | 21.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.2% | -6.4% | -2.0% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 13.5% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Net Income TTM | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | $1.48B | · | $1.48B | $1.48B | |
| Market Cap | $257.86B | $230.98B | $234.61B | $242.85B | · | · | · | · | · | · | · | |
| P/E | 32.7 | 31.5 | 34.4 | 31.2 | 34.3 | 29.2 | 35.4 | 30.9 | · | 27.7 | 28.8 | |
| P/S | 5.8 | 5.4 | 5.5 | 5.4 | · | · | · | · | · | · | · | |
| P/B | 4.8 | 4.7 | 5.0 | 5.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | 33.0 | 26.7 | 27.9 | 26.5 | · | · | · | · | · | · | · | |
| P / FCF | 41.0 | 31.8 | 33.9 | 35.1 | · | · | · | · | · | · | · | |
| Dividend Yield | 0.25% | 0.25% | 0.22% | 0.19% | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | 2.9% | 3.2% | 2.9% | 3.4% | 2.8% | 3.2% | · | 3.6% | 3.5% | |
| Payout Ratio | 9.5% | 9.2% | 8.8% | 6.5% | 5.1% | · | · | · | · | · | · | |
| Annual Payout | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $12.21B | $11.12B | $10.86B | $10.36B | $11.39B | $10.60B | $10.54B | $10.35B | $10.89B | $10.57B | $10.71B | $11.45B | |
| R&D Expense | $364M | $336M | $357M | $346M | $352M | $342M | $374M | $346M | $339M | $331M | $327M | $319M | $346M | $391M | |
| SG&A Expense | $2.33B | $2.18B | $2.35B | $2.16B | $2.14B | $2.08B | $2.20B | $2.10B | $2.11B | $2.18B | $2.13B | $2.05B | $2.12B | $2.30B | |
| Operating Expenses | $9.91B | $9.14B | $9.96B | $9.18B | $9.02B | $8.65B | $9.38B | $8.76B | $8.72B | $8.68B | $9.03B | $8.71B | $9.15B | $9.59B | |
| Operating Income | $2.09B | $1.86B | $2.25B | $1.94B | $1.83B | $1.72B | $2.02B | $1.84B | $1.82B | $1.66B | $1.85B | $1.86B | $1.56B | $1.86B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $363M | · | $359M | $300M | · | |
| Interest Income | $207M | $233M | $259M | $234M | $297M | $203M | $227M | $277M | $295M | $279M | $309M | $246M | $146M | $150M | |
| Other Non-op | $31M | $-9M | $6M | $-2M | $-19M | $3M | $13M | $-16M | $5M | $10M | $-33M | $14M | $-46M | $35M | |
| Pretax Income | $1.92B | $1.73B | $2.15B | $1.83B | $1.71B | $1.62B | $1.94B | $1.74B | $1.76B | $1.59B | $1.74B | $1.76B | $1.36B | $1.78B | |
| Income Tax | $167M | $70M | $153M | $207M | $92M | $95M | $149M | $99M | $128M | $281M | $133M | $53M | $46M | $173M | |
| Net Income | $1.74B | $1.65B | $1.96B | $1.62B | $1.62B | $1.51B | $1.83B | $1.63B | $1.55B | $1.33B | $1.65B | $1.70B | $1.29B | $1.57B | |
| EPS (Basic) | $4.68 | $4.44 | $5.22 | $4.28 | $4.28 | $3.99 | $4.80 | $4.26 | $4.05 | $3.47 | $4.21 | $4.44 | $3.34 | $4.03 | |
| EPS (Diluted) | $4.68 | $4.43 | $5.21 | $4.27 | $4.28 | $3.98 | $4.78 | $4.25 | $4.04 | $3.46 | $4.20 | $4.42 | $3.32 | $4.01 | |
| Shares (Basic) | 371,000,000 | 372,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 378,000,000 | -764,000,000 | 382,000,000 | 382,000,000 | 382,000,000 | 0 | 386,000,000 | 386,000,000 | 0 | |
| Shares (Diluted) | 371,000,000 | 373,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 379,000,000 | -768,000,000 | 384,000,000 | 383,000,000 | 384,000,000 | 0 | 388,000,000 | 388,000,000 | -1,000,000 | |
| EBITDA | $2.09B | $1.86B | · | $1.94B | $1.83B | $1.72B | · | $1.84B | $1.82B | $1.66B | · | $1.86B | $1.56B | · |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.06B | $3.25B | $9.85B | $1.98B | $4.58B | $4.13B | $4.01B | $4.64B | $7.07B | $5.50B | · | $6.15B | $3.48B | · | |
| Short-term Investments | $0 | $2M | $253M | $1.56B | $1.81B | $1.81B | $1.56B | $2.00B | $1.75B | $1.75B | · | · | · | · | |
| Receivables | $9.45B | $9.20B | $8.90B | $8.91B | $8.59B | $8.46B | $8.19B | $8.26B | $7.94B | $7.93B | · | $8.37B | $7.92B | · | |
| Inventory | $5.63B | $5.50B | $5.42B | $5.75B | $5.56B | $5.22B | $4.98B | $5.43B | $5.20B | $5.13B | · | $5.40B | $5.66B | · | |
| Other Current Assets | $2.54B | $2.68B | $2.61B | $2.47B | $2.60B | $2.39B | $1.96B | $1.91B | $2.02B | $1.90B | · | $1.70B | $1.77B | · | |
| Current Assets | $23.36B | $22.32B | $28.71B | $22.30B | $24.58B | $23.38B | $22.14B | $23.78B | $25.48B | $23.64B | · | $23.09B | $20.21B | · | |
| PP&E (Net) | $10.76B | $10.66B | $10.56B | $10.18B | $9.63B | $9.33B | $9.31B | $9.41B | $9.28B | $9.32B | · | $9.17B | $9.35B | · | |
| PP&E (Gross) | · | · | $18.38B | · | · | · | $16.06B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7.82B | · | · | · | $6.75B | · | · | · | · | · | · | · | |
| Goodwill | $54.83B | $55.19B | $49.36B | $49.29B | $47.25B | $46.49B | $45.85B | $46.73B | $43.84B | $43.84B | $44.02B | $43.58B | $43.14B | $41.20B | |
| Intangibles | $18.61B | $19.15B | $15.84B | $16.24B | $15.15B | $15.32B | $15.53B | $16.26B | $15.52B | $16.05B | · | $17.09B | $17.97B | · | |
| Other Non-current Assets | $5.62B | $5.97B | $5.87B | $5.02B | $4.62B | $4.52B | $4.49B | $4.18B | $4.38B | $4.24B | · | $4.12B | $3.98B | · | |
| Total Assets | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | $98.73B | $97.06B | $94.66B | $97.15B | |
| Accounts Payable | $3.27B | $3.34B | $3.62B | $3.12B | $2.98B | $3.05B | $3.08B | $2.61B | $2.55B | $2.56B | · | $2.51B | $2.80B | · | |
| Current Liabilities | $15.07B | $14.62B | $15.19B | $14.89B | $12.72B | $13.17B | $13.33B | $14.60B | $14.77B | $13.94B | · | $14.16B | $15.88B | · | |
| Capital Leases | · | · | $1.20B | · | · | · | $1.24B | · | · | · | · | · | · | · | |
| Deferred Tax | $1.58B | $2.11B | $1.49B | $842M | $624M | $1.04B | $1.27B | $1.12B | $1.52B | $1.81B | · | $2.62B | $2.98B | · | |
| Other Non-current Liabilities | $4.54B | $4.42B | $4.27B | $4.28B | $4.27B | $3.97B | $3.99B | $4.34B | $4.39B | $4.57B | · | $4.33B | $4.23B | · | |
| Long-term Debt | $42.28B | $42.95B | $39.17B | $35.48B | $35.03B | $33.99B | $31.07B | $35.11B | $35.20B | $35.39B | · | $35.08B | $35.05B | · | |
| Common Stock | $446M | $445M | $445M | $445M | $444M | $444M | $444M | $444M | $443M | $443M | · | $442M | $441M | · | |
| Retained Earnings | $62.19B | $60.63B | $59.16B | $57.35B | $55.90B | $54.45B | $53.10B | $51.42B | $49.94B | $48.54B | · | $45.87B | $43.06B | · | |
| Treasury Stock | $26.37B | $25.36B | $22.31B | $22.31B | $21.27B | $21.27B | $19.23B | $18.23B | $18.19B | $18.19B | · | $15.12B | $15.08B | · | |
| AOCI | $-2.46B | $-2.50B | $-2.45B | $-2.80B | $-2.80B | $-2.34B | $-2.70B | $-2.48B | $-2.41B | $-2.76B | · | $-3.03B | $-3.05B | · | |
| Stockholders' Equity | $52.68B | $51.93B | $53.41B | $51.02B | $50.51B | $49.39B | $49.58B | $48.99B | $47.43B | $45.52B | · | $45.33B | $42.26B | · | |
| Liabilities + Equity | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | · | $97.06B | $94.66B | · | |
| Shares Outstanding | 446,000,000 | 445,000,000 | 445,000,000 | 445,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 443,000,000 | 443,000,000 | 442,000,000 | 442,000,000 | 441,000,000 | 441,000,000 |
Flujo de Efectivo 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $82M | $83M | $84M | $70M | $81M | $75M | $79M | $68M | $84M | $70M | $61M | $67M | $76M | $75M | |
| Deferred Tax | $-208M | $-258M | $89M | $-127M | $-322M | $-279M | $-202M | $-400M | · | · | · | · | · | · | |
| Amort. of Intangibles | $485M | $430M | $436M | $435M | $430M | $429M | $438M | $449M | $514M | $551M | $563M | $584M | $606M | $592M | |
| Restructuring | $38M | $34M | $36M | $62M | $56M | $43M | $20M | $26M | $26M | $25M | $19M | $38M | $50M | $37M | |
| Operating Cash Flow | $2.12B | $1.19B | $3.46B | $2.24B | $1.40B | $723M | $3.29B | $2.17B | $1.96B | $1.25B | $3.72B | $2.41B | $729M | $3.49B | |
| CapEx | $450M | $376M | $465M | $404M | $294M | $362M | $480M | $272M | $301M | $347M | $405M | $332M | $458M | $550M | |
| Investing Cash Flow | $164M | $-8.96B | $891M | $-4.12B | $-288M | $-527M | $20M | $-3.58B | $-253M | $-2.03B | $-376M | $-1.18B | $-3.14B | $-525M | |
| Debt Issued | $0 | $5.24B | $4.92B | $0 | $0 | $2.84B | $0 | $0 | $-1M | $1.21B | $2.48B | $3.47B | $0 | $3.19B | |
| Net Debt Issued | · | $3.83B | · | · | · | $2.00B | · | · | · | $1.21B | · | · | $0 | · | |
| Stock Repurchased | $1.00B | $3.00B | $37M | $963M | $0 | $2.00B | $1.00B | $0 | $0 | $3.00B | $0 | $0 | $3.00B | $1.00B | |
| Net Stock Activity | · | $-3.00B | · | · | · | $-2.00B | · | · | · | $-3.00B | · | · | $-3.00B | · | |
| Dividends Paid | $175M | $162M | $162M | $163M | $162M | $149M | $149M | $150M | $149M | $135M | $136M | $135M | $117M | $117M | |
| Financing Cash Flow | $-1.57B | $1.09B | $3.53B | $-632M | $-991M | $-102M | $-3.67B | $-1.19B | $-115M | $-1.82B | $-1.43B | $1.85B | $-2.59B | $2.39B | |
| Net Change in Cash | $817M | $-6.60B | $7.87B | $-2.59B | $431M | $132M | $-630M | $-2.43B | $1.58B | $-2.58B | $1.93B | $3.02B | $-5.04B | $5.60B | |
| Free Cash Flow | · | $816M | · | · | · | $361M | · | · | · | $904M | · | · | $271M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $605M | · | · | $-19M | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| Net Margin | 14.5% | 15.0% | · | 14.5% | 14.9% | 14.6% | · | 15.4% | 14.7% | 12.9% | · | 16.0% | 12.1% | · | |
| Pretax Margin | 16.0% | 15.8% | · | 16.4% | 15.7% | 15.6% | · | 16.4% | 16.7% | 15.4% | · | 16.7% | 12.7% | · | |
| EBITDA Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| ROA | 1.6% | 1.6% | · | 1.6% | 1.6% | 1.5% | · | 1.7% | 1.6% | 1.4% | · | 1.8% | · | · | |
| ROE | 3.4% | 3.3% | · | 3.2% | 3.3% | 3.2% | · | 3.5% | 3.4% | 3.0% | · | 3.8% | · | · | |
| ROIC | 3.6% | 3.4% | · | 3.4% | 3.4% | 3.3% | · | 3.5% | 3.6% | 3.0% | · | 4.0% | · | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.5 | · | 1.5 | 1.9 | 1.8 | · | 1.6 | 1.7 | 1.7 | · | 1.6 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | 0.8 | 1.2 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.6 | · | 5.2 | 5.2 | · |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.98B | $43.35B | · | $42.94B | $42.36B | $41.85B | · | $42.06B | $42.15B | $42.32B | · | $42.65B | $44.17B | · | |
| Net Income TTM | $6.62B | $6.39B | · | $6.37B | $6.31B | $6.02B | · | $6.20B | $5.94B | $5.68B | · | $5.85B | $6.68B | · | |
| Market Cap | $228.81B | $210.65B | · | $206.59B | $181.28B | $222.07B | · | $272.80B | $244.98B | $257.48B | · | $223.73B | · | · | |
| P/E | 29.1 | 27.9 | · | 27.7 | 24.7 | 31.8 | · | 38.0 | 35.8 | 39.5 | · | 33.7 | 34.0 | · | |
| P/S | 5.1 | 4.9 | · | 4.8 | 4.3 | 5.3 | · | 6.5 | 5.8 | 6.1 | · | 5.2 | · | · | |
| P/B | 4.3 | 4.1 | · | 4.0 | 3.6 | 4.5 | · | 5.6 | 5.2 | 5.7 | · | 4.9 | · | · | |
| P / Cash Flow | · | 176.7 | · | · | · | 307.2 | · | · | · | 205.8 | · | · | · | · | |
| P / FCF | · | 258.1 | · | · | · | 615.2 | · | · | · | 284.8 | · | · | · | · | |
| Earnings Yield | 3.4% | 3.6% | · | 3.6% | 4.0% | 3.1% | · | 2.6% | 2.8% | 2.5% | · | 3.0% | 2.9% | · | |
| Payout Ratio | · | 9.8% | · | · | · | 9.9% | · | · | · | 10.1% | · | · | 9.1% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Ingresos | $44.56B | — | — | $42.88B | — |
| Margen Operativo % | 17.4% | — | — | 17.1% | — |
| Beneficio neto | $6.70B | — | — | $6.33B | — |
| EPS Diluido | $17.74 | — | — | $16.53 | — |
Balance general
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Ratio corriente | 1.9 | — | — | 1.7 | — |
| Ratio Rápido | 1.3 | — | — | 1.0 | — |
Flujo de Efectivo
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $6.29B | — | — | $7.27B | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
- Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?
- ¿Les Gustan a los Analistas de Wall Street las Acciones de Thermo Fisher Scientific?
- Thermo Fisher Scientific Inc. (TMO) Desvela Centro de Diseño de Bioprocesos para Desarrollar Terapias que Cambian Vidas
- Jim Cramer sobre Thermo Fisher: “Creo que puedes comprarla a este nivel”
- TD Cowen reduce el precio objetivo de Thermo Fisher (TMO), mantiene la calificación de compra.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 2 893 declarantes · $107.2B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 196 (-6 vs trimestre anterior) | 140 (-78 vs trimestre anterior) | 925 (-41 vs trimestre anterior) | 1 116 (+29 vs trimestre anterior) | +59.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $12 171 173 789 | 24 276 316 | 11,35% | Acciones |
| STATE STREET CORP | $8 443 627 719 | 16 825 879 | 7,87% | Acciones |
| FMR LLC | $4 526 822 682 | 9 029 086 | 4,22% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 572 029 397 | 7 164 352 | 3,33% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 121 552 090 | 6 226 169 | 2,91% | Acciones |
| Capital World Investors | $3 106 193 041 | 6 195 370 | 2,90% | Acciones |
| NORGES BANK | $2 550 871 048 | 5 087 903 | 2,38% | Acciones |
| Capital Research Global Investors | $2 079 461 815 | 4 147 545 | 1,94% | Acciones |
| Capital International Investors | $1 595 416 232 | 3 182 151 | 1,49% | Acciones |
| Dodge & Cox | $1 531 543 498 | 3 054 778 | 1,43% | Acciones |
| Fisher Asset Management, LLC | $1 461 823 432 | 2 915 715 | 1,36% | Acciones |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1 373 321 891 | 2 739 191 | 1,28% | Acciones |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1 371 130 859 | 2 734 823 | 1,28% | Acciones |
| EdgePoint Investment Group Inc. | $1 092 789 324 | 2 179 650 | 1,02% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 046 130 256 | 2 086 585 | 0,98% | Acciones |
| Unisphere Establishment | $1 032 801 600 | 2 060 000 | 0,96% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 009 204 590 | 2 012 934 | 0,94% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $993 831 390 | 1 982 271 | 0,93% | Acciones |
| VIKING GLOBAL INVESTORS LP | $971 342 384 | 1 937 415 | 0,91% | Acciones |
| FLOSSBACH VON STORCH SE | $955 579 626 | 1 905 975 | 0,89% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $908 857 157 | 1 849 037 | 0,85% | Acciones |
| 1832 Asset Management L.P. | $863 062 662 | 1 721 443 | 0,80% | Acciones |
| Clearbridge Investments, LLC | $847 834 531 | 1 691 069 | 0,79% | Acciones |
| PARNASSUS INVESTMENTS, LLC | $822 024 341 | 1 639 589 | 0,77% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $768 919 799 | 1 533 667 | 0,72% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $667 185 605 | 1 330 750 | 0,62% | Acciones |
| Temasek Holdings (Private) Ltd | $583 447 171 | 1 163 729 | 0,54% | Acciones |
| BlackRock, Inc. | $579 344 543 | 1 155 546 | 0,54% | Acciones |
| LOOMIS SAYLES & CO L P | $571 001 278 | 1 138 905 | 0,53% | Acciones |
| LAZARD ASSET MANAGEMENT LLC | $567 301 499 | 1 131 525 | 0,53% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $541 170 491 | 1 079 405 | 0,50% | Acciones |
| Pictet Asset Management Holding SA | $538 406 962 | 1 073 670 | 0,50% | Acciones |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $526 019 392 | 1 049 185 | 0,49% | Acciones |
| Swiss National Bank | $525 485 443 | 1 048 120 | 0,49% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $505 067 056 | 1 007 394 | 0,47% | Acciones |
| Rathbones Group PLC | $504 097 425 | 1 005 460 | 0,47% | Acciones |
| UBS Group AG | $503 596 066 | 1 004 460 | 0,47% | Acciones |
| BANK OF AMERICA CORP /DE/ | $488 690 042 | 974 729 | 0,46% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $450 916 165 | 899 386 | 0,42% | Acciones |
| Veritas Asset Management LLP | $442 637 207 | 882 873 | 0,41% | Acciones |
| Focus Partners Wealth | $431 444 332 | 860 536 | 0,40% | Acciones |
| FIRST MANHATTAN CO. LLC. | $422 447 886 | 841 894 | 0,39% | Acciones |
| National Pension Service | $422 118 548 | 841 947 | 0,39% | Acciones |
| GOLDMAN SACHS GROUP INC | $417 251 345 | 832 239 | 0,39% | Acciones |
| D1 Capital Partners L.P. | $409 672 787 | 817 123 | 0,38% | Acciones |
| W1M Asset Management Ltd | $408 009 352 | 814 886 | 0,38% | Acciones |
| Vanguard Global Advisers, LLC | $401 921 762 | 801 663 | 0,37% | Acciones |
| Legal & General Group Plc | $393 992 751 | 785 848 | 0,37% | Acciones |
| BARCLAYS PLC | $383 005 951 | 763 934 | 0,36% | Acciones |
| AMERIPRISE FINANCIAL INC | $373 268 191 | 744 431 | 0,35% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $369 918 950 | 737 831 | 0,34% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $365 892 528 | 729 800 | 0,34% | Acciones |
| VANGUARD GROUP INC | $354 408 424 | 611 629 | 0,33% | Acciones |
| California Public Employees Retirement System | $349 327 092 | 696 759 | 0,33% | Acciones |
| KING LUTHER CAPITAL MANAGEMENT CORP | $339 577 646 | 677 313 | 0,32% | Acciones |
| W1M Investment Management Ltd | $335 034 706 | 691 342 | 0,31% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $321 963 477 | 642 176 | 0,30% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $319 519 265 | 637 305 | 0,30% | Acciones |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $314 473 046 | 627 240 | 0,29% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $309 344 243 | 616 961 | 0,29% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $307 944 336 | 614 218 | 0,29% | Acciones |
| D. E. Shaw & Co., Inc. | $307 017 322 | 612 369 | 0,29% | Acciones |
| JANUS HENDERSON GROUP PLC | $301 030 667 | 612 436 | 0,28% | Acciones |
| RHUMBLINE ADVISERS | $297 780 694 | 593 946 | 0,28% | Acciones |
| Ninety One UK Ltd | $297 641 362 | 593 668 | 0,28% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $296 956 107 | 592 301 | 0,28% | Acciones |
| Mirova US LLC | $296 432 610 | 591 257 | 0,28% | Acciones |
| Robeco Institutional Asset Management B.V. | $289 599 072 | 577 627 | 0,27% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $281 062 261 | 571 811 | 0,26% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $274 562 786 | 547 636 | 0,26% | Acciones |
| Eurizon Capital SGR S.p.A. | $271 488 657 | 539 965 | 0,25% | Acciones |
| APG Asset Management N.V. | $266 543 464 | 607 825 | 0,25% | Acciones |
| Longview Partners (Guernsey) LTD | $265 608 495 | 529 776 | 0,25% | Acciones |
| CITADEL ADVISORS LLC | $263 486 238 | 525 543 | 0,25% | Acciones |
| Lindsell Train Ltd | $257 955 736 | 514 512 | 0,24% | Acciones |
| Southpoint Capital Advisors LP | $250 680 000 | 500 000 | 0,23% | Acciones |
| Qube Research & Technologies Ltd | $246 959 909 | 492 580 | 0,23% | Acciones |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $245 733 399 | 490 134 | 0,23% | Acciones |
| CI INVESTMENTS INC. | $235 771 058 | 470 263 | 0,22% | Acciones |
| Balyasny Asset Management L.P. | $225 425 494 | 449 628 | 0,21% | Acciones |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $223 014 454 | 444 819 | 0,21% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $221 174 247 | 431 114 | 0,21% | Acciones |
| ROYAL LONDON ASSET MANAGEMENT LTD | $217 246 307 | 433 314 | 0,20% | Acciones |
| M&G PLC | $214 820 283 | 428 783 | 0,20% | Acciones |
| Liontrust Investment Partners LLP | $211 478 390 | 364 964 | 0,20% | Acciones |
| Cryder Capital Partners LLP | $210 160 586 | 419 181 | 0,20% | Acciones |
| FIFTH THIRD BANCORP | $209 624 364 | 418 112 | 0,20% | Acciones |
| JANE STREET GROUP, LLC | $205 206 648 | 409 300 | 0,19% | Opción de venta |
| JANE STREET GROUP, LLC | $204 905 832 | 408 700 | 0,19% | Opción de compra |
| Ensign Peak Advisors, Inc | $204 085 607 | 407 064 | 0,19% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $203 978 817 | 406 851 | 0,19% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $203 629 369 | 406 154 | 0,19% | Acciones |
| AVIVA PLC | $202 744 469 | 404 389 | 0,19% | Acciones |
| Navera Investment Management Ltd. | $199 087 273 | 397 439 | 0,19% | Acciones |
| FIL Ltd | $198 044 720 | 395 015 | 0,18% | Acciones |
| CIBC Bancorp USA Inc. | $190 068 606 | 378 891 | 0,18% | Acciones |
| Alyeska Investment Group, L.P. | $188 546 957 | 376 071 | 0,18% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $187 568 351 | 373 510 | 0,17% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $180 518 000 | 360 056 | 0,17% | Acciones |
| Railway Pension Investments Ltd | $179 973 199 | 358 970 | 0,17% | Acciones |
Informantes de la empresa 60 insiders · 29 directivos · 28 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Marijn E Dekkers | Chief Executive Officer | 17 de agosto de 2009 F | 42 554 | 0 | 0 | $0 |
| Stephen Williamson | Retiring Sr. VP and CFO | 28 de febrero de 2026 F | 32 499 | 0 | 0 | $0 |
| Kyriazi Theo Melas | VP & Chief Financial Officer | 16 de septiembre de 2004 M | 158 199 | 0 | 0 | $0 |
| Gianluca Pettiti | President & COO | 27 de julio de 2026 S | 24 651 | 0 | 6 | $-2 582 704 |
| Mark Stevenson | Retiring Executive VP & COO | 25 de febrero de 2022 F | 62 141 | 0 | 0 | $0 |
| Frederick M. Lowery | Executive Vice President | 28 de febrero de 2026 F | 15 044 | 0 | 2 | $-8 154 131 |
| Michel Lagarde | Executive Vice President | 28 de febrero de 2026 F | 85 151 | 0 | 5 | $-51 307 290 |
| Thomas B Shropshire Jr. | SVP and General Counsel | 25 de febrero de 2026 A | 6 058 | 0 | 0 | $0 |
| Michael A Boxer | SVP and General Counsel | 10 de marzo de 2025 S | 10 816 | 0 | 0 | $0 |
| Syed A. Jafry | Sr. Vice President | 26 de febrero de 2021 F | 22 349 | 0 | 0 | $0 |
| Peter E Hornstra | VP & Chief Accounting Officer | 26 de febrero de 2021 F | 1 962 | 0 | 0 | $0 |
| Patrick M Durbin | Senior Vice President | 28 de agosto de 2019 F | 38 868 | 0 | 0 | $0 |
| Gregory J. Herrema | Senior Vice President | 28 de agosto de 2019 F | 26 967 | 0 | 0 | $0 |
| Seth H Hoogasian | Sr. VP & Retiring Gen. Counsel | 28 de febrero de 2018 F | 26 530 | 0 | 0 | $0 |
| Shine Daniel P | Senior Vice President | 30 de agosto de 2017 S | 20 682 | 0 | 0 | $0 |
| Thomas W Loewald | Senior Vice President | 28 de agosto de 2017 F | 38 133 | 0 | 0 | $0 |
| Peter M Wilver | Exec. VP & Chief Admin Officer | 15 de marzo de 2017 S | 62 517 | 0 | 0 | $0 |
| Alan J Malus | Executive Vice President | 10 de marzo de 2016 M | 47 286 | 0 | 0 | $0 |
| Andrew J Thomson | Senior Vice President | 26 de agosto de 2015 F | 52 389 | 0 | 0 | $0 |
| Edward A Pesicka | Senior Vice President | 5 de marzo de 2015 M | 80 641 | 0 | 0 | $0 |
| Kenneth Berger | Senior Vice President | 26 de febrero de 2012 F | 36 128 | 0 | 0 | $0 |
| Stephen G Sheehan | Sr. VP, Human Resources | 5 de marzo de 2010 F | 4 396 | 0 | 0 | $0 |
| Yuh-Geng Tsay | Senior Vice President | 26 de febrero de 2010 F | 110 369 | 0 | 0 | $0 |
| Alexander G Stachtiaris | Sr. VP, Global Bus. Services | 5 de marzo de 2008 A | 17 236 | 0 | 0 | $0 |
| Fredric T Walder | Sr. VP, Customer Excellence | 5 de marzo de 2008 A | 16 730 | 0 | 0 | $0 |
| Guy Broadbent | Senior Vice President | 5 de marzo de 2008 A | 31 545 | 0 | 0 | $0 |
| Joseph R Massaro | Sr. VP, Global Bus. Services | 16 de noviembre de 2007 S | 15 000 | 0 | 0 | $0 |
| SYRON RICHARD F/CA | Executive Chairman | 12 de diciembre de 2003 S | 80 320 | 0 | 0 | $0 |
| Barry S Howe | VP, Measurement & Control | 31 de julio de 2003 M | 23 247 | 0 | 0 | $0 |
| Alexandra R. Keith | Consejero | 27 de junio de 2026 A | 2 602 | 0 | 0 | $0 |
| Dion J Weisler | Consejero | 27 de junio de 2026 A | 5 446 | 0 | 0 | $0 |
| Karen S Lynch | Consejero | 27 de junio de 2026 A | 1 159 | 0 | 0 | $0 |
| Scott M Sperling | Consejero | 27 de junio de 2026 A | 69 479 | 0 | 0 | $0 |
| Jennifer M Johnson | Consejero | 27 de junio de 2026 A | 1 403 | 0 | 0 | $0 |
| Debora L Spar | Consejero | 20 de mayo de 2026 A | 2 610 | 0 | 0 | $0 |
| Tyler Jacks | Consejero | 20 de mayo de 2026 A | 9 462 | 0 | 0 | $0 |
| Ruby R Chandy | Consejero | 20 de mayo de 2026 A | 3 463 | 0 | 0 | $0 |
| Nelson Chai | Consejero | 20 de mayo de 2026 A | 15 316 | 0 | 0 | $0 |
| Martin C Harris | Consejero | 20 de mayo de 2026 A | 9 532 | 0 | 0 | $0 |
| MULLEN JAMES C | Consejero | 21 de mayo de 2025 A | 3 393 | 0 | 0 | $0 |
| Lars Rebien Sorensen | Consejero | 22 de mayo de 2024 F | 9 233 | 0 | 0 | $0 |
| Jim P Manzi | Consejero | 3 de febrero de 2023 S | 14 807 | 0 | 0 | $0 |
| Thomas J Lynch | Consejero | 5 de noviembre de 2021 G | 10 257 | 0 | 0 | $0 |
| Judy C Lewent | Consejero | 20 de mayo de 2020 A | 1 290 | 0 | 0 | $0 |
| Elaine Ullian | Consejero | 22 de mayo de 2019 A | 4 706 | 0 | 0 | $0 |
| William G Parrett | Consejero | 23 de febrero de 2018 S | 11 660 | 0 | 0 | $0 |
| Michael E Porter | Consejero | 9 de marzo de 2012 M | 14 640 | 0 | 0 | $0 |
| Peter J Manning | Consejero | 25 de mayo de 2011 A | 6 548 | 0 | 0 | $0 |
| Michael Adam Bell | Consejero | 20 de mayo de 2010 A | 8 192 | 0 | 0 | $0 |
| Stephen P Kaufman | Consejero | 20 de mayo de 2010 A | 9 192 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 22 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Pharmaceutical Product Development, LLC, Wildcat Acquisition Holdings (UK) Limited, Jaguar Holding Company II, Jaguar Holding Company I, LLC, Eagle Holding Company II, LLC, PPD, Inc., Thermo Fisher Scientific Powder US Holdings Corp., Thermo Fisher Scientific Inc., Fisher Scientific International LLC, Fisher Scientific Worldwide Inc., Spectra-Physics Holdings USA, LLC, Thermo Fisher Scientific Powder Holdings I Ltd, Thermo Fisher Scientific Powder Holdings II Ltd, Thermo Fisher Scientific Powder Holdings III Ltd, Thermo Fisher Scientific Powder Holdings IV Ltd, Thermo Fisher Scientific Powder US Holdings Ltd ×2 presentaciones | 14 de marzo de 2024 | — | Presentación inicial | M&A / venta | SEC |
| Thermo Fisher Scientific Inc., Thermo Fisher (CN) Luxembourg S.à r.l. ×2 presentaciones | 13 de septiembre de 2017 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 30 de junio de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 11 de mayo de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 24 de marzo de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 2 de marzo de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de julio de 2004 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 27 de julio de 2004 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de octubre de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 17 de octubre de 2002 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 16 de octubre de 2002 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 4 de abril de 2002 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 1 de abril de 2002 | — | Presentación inicial | — | SEC |
| Thermo Electron Corporation IRS No. ×5 presentaciones | 27 de diciembre de 2001 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 21 de noviembre de 2001 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 213 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| GDOC · Goldman Sachs ETF Trust | 4,52% | 1 847 NS | 31 de mayo de 2026 | N-PORT |
| AGIQ · Tidal Trust I | 3,99% | 918 NS | 31 de mayo de 2026 | N-PORT |
| HRTS · Tema ETF Trust | 3,97% | 4 185 NS | 31 de mayo de 2026 | N-PORT |
| IYH · iShares Trust | 3,51% | 222 608 SH | 8 de agosto de 2026 | Diario |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 3,19% | 740 NS | 30 de abril de 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,12% | 1 576 NS | 30 de junio de 2026 | N-PORT |
| QLTY · GMO ETF Trust | 2,94% | 269 227 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,91% | 173 204 NS | 30 de abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 2,74% | 1 117 168 SH | 8 de agosto de 2026 | Diario |
| IXJ · iShares Trust | 2,72% | 195 170 SH | 8 de agosto de 2026 | Diario |
| RXL · ProShares Trust | 2,68% | 3 918 NS | 31 de mayo de 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,66% | 72 927 NS | 30 de abril de 2026 | N-PORT |
| TOLL · Tema ETF Trust | 2,63% | 2 616 NS | 31 de mayo de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,59% | 7 491 NS | 30 de abril de 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 2,39% | 1 916 NS | 30 de abril de 2026 | N-PORT |
| KAT · Advisors Series Trust | 2,24% | 30 779 NS | 31 de marzo de 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,99% | 2 213 NS | 30 de abril de 2026 | N-PORT |
| CAML · Professionally Managed Portfolios | 1,88% | 14 779 NS | 30 de abril de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,86% | 24 566 SH | 8 de agosto de 2026 | Diario |
| PEXL · Pacer Funds Trust | 1,67% | 1 592 NS | 30 de abril de 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 1,64% | 2 250 NS | 31 de mayo de 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 1,63% | 3 902 NS | 31 de mayo de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,53% | 1 276 NS | 31 de mayo de 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,43% | 41 397 NS | 30 de abril de 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,41% | 4 289 NS | 31 de marzo de 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,32% | 1 154 NS | 30 de abril de 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,26% | 5 900 NS | 29 de mayo de 2026 | N-PORT |
| ALRG · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,22% | 189 NS | 30 de abril de 2026 | N-PORT |
| LRGC · AB Active ETFs, Inc. | 1,20% | 30 508 NS | 31 de mayo de 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,16% | 54 333 SH | 8 de agosto de 2026 | Diario |
| MFSG · MFS Active Exchange Traded Funds Tr… | 1,16% | 8 091 NS | 31 de mayo de 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 1,08% | 654 NS | 31 de mayo de 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 1,02% | 3 416 NS | 30 de abril de 2026 | N-PORT |
| FFND · Northern Lights Fund Trust II | 1,02% | 2 122 NS | 31 de mayo de 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,88% | 233 578 SH | 8 de agosto de 2026 | Diario |
| CAPE · DoubleLine ETF Trust | 0,86% | 4 580 NS | 31 de marzo de 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,85% | 2 247 NS | 31 de mayo de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,84% | 15 398 NS | 30 de abril de 2026 | N-PORT |
| USXF · iShares Trust | 0,84% | 21 650 SH | 8 de agosto de 2026 | Diario |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,81% | 28 441 000 | 8 de agosto de 2026 | Diario |
| ZECP · Zacks Trust | 0,80% | 5 541 NS | 31 de mayo de 2026 | N-PORT |
| IWX · iShares Trust | 0,79% | 54 993 SH | 8 de agosto de 2026 | Diario |
| TAX · EA Series Trust | 0,79% | 408 NS | 29 de mayo de 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,75% | 409 NS | 30 de abril de 2026 | N-PORT |
| OEI · Listed Funds Trust | 0,75% | 656 NS | 30 de abril de 2026 | N-PORT |
| IVE · iShares Trust | 0,72% | 615 615 SH | 8 de agosto de 2026 | Diario |
| FFLC · FIDELITY COVINGTON TRUST | 0,72% | 16 950 NS | 30 de abril de 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,71% | 1 284 NS | 30 de abril de 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,70% | 3 534 266 SH | 8 de agosto de 2026 | Diario |
| IUSV · iShares Trust | 0,68% | 322 866 SH | 8 de agosto de 2026 | Diario |